Press releases

29
Jul 2021
20:06 E.S.T.

Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT

Read more
14
Jun 2021
18:11 E.S.T.

Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

Read more
2
Jun 2021
06:35 E.S.T.

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021

Read more
11
May 2021
17:05 E.S.T.

Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T

Read more
6
May 2021
18:28 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021

Read more
26
Apr 2021
19:06 E.S.T.

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021

Read more
9
Apr 2021
04:00 E.S.T.

Cellectis Completes Sale of $47 million through its ATM program

Read more
29
Mar 2021
18:48 E.S.T.

Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq

Read more
4
Mar 2021
19:59 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results

Read more
25
Feb 2021
20:29 E.S.T.

Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US